{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:51:58Z","timestamp":1791593518096,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Japan Society for Promotion of Science"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.bmcl.2018.01.012","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T03:30:19Z","timestamp":1515727819000},"page":"707-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4948-5809","authenticated-orcid":false,"given":"Shusuke","family":"Tomoshige","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0565-6503","authenticated-orcid":false,"given":"Kenji","family":"Ohgane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2018.01.012_b0005","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat Rev Dis Primer"},{"key":"10.1016\/j.bmcl.2018.01.012_b0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","author":"S\u00e1nchez","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.01.012_b0015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/cmdc.201100585","article-title":"Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms","volume":"7","author":"Liu","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0020","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/nm1066","article-title":"Protein aggregation and neurodegenerative disease","volume":"10","author":"Ross","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.bmcl.2018.01.012_b0025","doi-asserted-by":"crossref","first-page":"11530","DOI":"10.1002\/anie.201706529","article-title":"Discovery of small molecules that induce degradation of huntingtin","volume":"56","author":"Tomoshige","year":"2017","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmcl.2018.01.012_b0030","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1021\/acs.chemrev.7b00077","article-title":"Small-molecule modulation of protein homeostasis","volume":"117","author":"Burslem","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2018.01.012_b0035","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1074\/jbc.M709525200","article-title":"Small molecules destabilize cIAP1 by activating auto-ubiquitylation","volume":"283","author":"Sekine","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0040","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1021\/ja100691p","article-title":"Protein knockdown using methyl bestatin-ligand hybrid molecules: design and synthesis of inducers of ubiquitination-mediated degradation of cellular retinoic acid-Binding proteins","volume":"132","author":"Itoh","year":"2010","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2018.01.012_b0045","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmc.2011.03.057","article-title":"Development of target protein-selective degradation inducer for protein knockdown","volume":"19","author":"Itoh","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0050","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.bmc.2011.09.041","article-title":"Design, synthesis and biological evaluation of nuclear receptor-degradation inducers","volume":"19","author":"Itoh","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0055","doi-asserted-by":"crossref","first-page":"9746","DOI":"10.1039\/C5OB01395J","article-title":"Degradation of HaloTag-fused nuclear proteins using BE04-HaloTag ligand hybrid molecules","volume":"13","author":"Tomoshige","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0060","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1016\/j.bmcl.2016.09.041","article-title":"Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand","volume":"26","author":"Demizu","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.01.012_b0065","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.1038\/cddis.2014.471","article-title":"Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway","volume":"5","author":"Ohoka","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.bmcl.2018.01.012_b0070","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1016\/j.bmcl.2012.04.134","article-title":"Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist","volume":"22","author":"Itoh","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmcl.2018.01.012_b0075","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/j.bmc.2016.05.035","article-title":"Efficient protein knockdown of HaloTag-fused proteins using hybrid molecules consisting of IAP antagonist and HaloTag ligand","volume":"24","author":"Tomoshige","year":"2016","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0080","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1074\/jbc.M116.768853","article-title":"In vivo knockdown of pathogenic proteins via specific and nongenetic inhibitor of apoptosis protein (IAP)-dependent protein erasers (SNIPERs)","volume":"292","author":"Ohoka","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0085","doi-asserted-by":"crossref","unstructured":"Okitsu, K, Hattori, T, Misawa, T, et al. Development of a small hybrid molecule that mediates degradation of His-Tag fused proteins. J Med Chem 2018. http:\/\/doi.org\/10.1021\/acs.jmedchem.7b00413","DOI":"10.1021\/acs.jmedchem.7b00413"},{"key":"10.1016\/j.bmcl.2018.01.012_b0090","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1126\/science.aab1433","article-title":"Phthalimide conjugation as a strategy for in vivo target protein degradation","volume":"348","author":"Winter","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2018.01.012_b0095","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1021\/acscentsci.6b00280","article-title":"Protein degradation by in-cell self-assembly of proteolysis targeting chimeras","volume":"2","author":"Lebraud","year":"2016","journal-title":"ACS Central Sci"},{"key":"10.1016\/j.bmcl.2018.01.012_b0100","doi-asserted-by":"crossref","unstructured":"Bing, Z, Hu, J, Xu, F, et al. Discovery of a small-molecule degrader of bromodomain and extra-terminal proteins with picomolar cellular potencies and capable of achieving tumor regression. J Med Chem 2018. http:\/\/doi.org\/10.1021\/acs.jmedchem.6b01816.","DOI":"10.1021\/acs.jmedchem.6b01816"},{"key":"10.1016\/j.bmcl.2018.01.012_b0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature21688","article-title":"Transcription control by the ENL YEATS domain in acute leukaemia","volume":"543","author":"Erb","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bmcl.2018.01.012_b0110","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1021\/ja209924v","article-title":"Targeting the con Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL\/HIF-1\u03b1 interaction","volume":"134","author":"Buckley","year":"2012","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmcl.2018.01.012_b0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nchembio.1858","article-title":"Catalytic in vivo protein knockdown by small-molecule PROTACs","volume":"11","author":"Bonderson","year":"2015","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.bmcl.2018.01.012_b0120","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1021\/acschembio.5b00442","article-title":"HaloPROTACs: use of small molecule PROTACs to induce degradation of HaloTag fusion proteins","volume":"10","author":"Buckley","year":"2015","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmcl.2018.01.012_b0125","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1111\/cas.13284","article-title":"Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands","volume":"108","author":"Shibata","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bmcl.2018.01.012_b0130","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/S0024-3205(01)01232-2","article-title":"Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain","volume":"69","author":"Klunk","year":"2001","journal-title":"Life Sci"},{"key":"10.1016\/j.bmcl.2018.01.012_b0135","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1039\/c1md00034a","article-title":"Phenyldiazenyl benzothiazole derivatives as probes for in vivo imaging of neurofibrillary tangles in Alzheimer's disease brains","volume":"2","author":"Matsumura","year":"2011","journal-title":"MedChemComm"},{"key":"10.1016\/j.bmcl.2018.01.012_b0140","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.10.030","article-title":"IAP antagonists induce autoubiquitination of c-IAPs, NF\u03baB activation, and TNF \u03b1-dependent apoptosis","volume":"131","author":"Varfolomeev","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bmcl.2018.01.012_b0145","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1111\/cas.13198","article-title":"SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib","volume":"108","author":"Ohoka","year":"2017","journal-title":"Cancer Sci"},{"key":"10.1016\/j.bmcl.2018.01.012_b0150","doi-asserted-by":"crossref","first-page":"11635","DOI":"10.1074\/jbc.M412042200","article-title":"Co-chaperone CHIP associates with expanded polyglutamine protein and promotes their degradation by proteasomes","volume":"280","author":"Jana","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0155","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.96.8.4604","article-title":"Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington\u2019s disease pathology","volume":"96","author":"Scherzinger","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.bmcl.2018.01.012_b0160","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1039\/c2ob07157f","article-title":"Short polyglutamine peptide forms a high-affinity binding site for thioflavin-T at the N-terminus","volume":"10","author":"Matsuoka","year":"2012","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmcl.2018.01.012_b0165","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1471-4159.2007.04972.x","article-title":"Congo red and thioflavin-T analogs detect A\u03b2 oligomers","volume":"104","author":"Maezawa","year":"2008","journal-title":"J Neurochem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X18300258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:23:23Z","timestamp":1760772203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X18300258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0960894X18300258"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.012","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degradation of huntingtin mediated by a hybrid molecule composed of IAP antagonist linked to phenyldiazenyl benzothiazole derivative","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2018.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}